Wells Fargo’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.7K | Buy |
|
|||||
2025
Q1 | $8.02K | Sell |
|
|||||
2024
Q4 | $34.5K | Sell |
|
|||||
2024
Q3 | $63.5K | Buy |
|
|||||
2024
Q2 | $62.1K | Buy |
|
|||||
2024
Q1 | $85.6K | Sell |
|
|||||
2023
Q4 | $44.5K | Buy |
|
|||||
2023
Q3 | $42.7K | Sell |
|
|||||
2023
Q2 | $55.7K | Buy |
|
|||||
2023
Q1 | $6.76K | Hold |
|
|||||
2022
Q4 | $9.05K | Hold |
|
|||||
2022
Q3 | $6K | Hold |
|
|||||
2022
Q2 | $10K | Sell |
|
|||||
2022
Q1 | $15K | Buy |
|
|||||
2021
Q4 | $20K | Hold |
|
|||||
2021
Q3 | $27K | Sell |
|
|||||
2021
Q2 | $67K | Buy |
|
|||||
2021
Q1 | $61K | Buy |
|
|||||
2020
Q4 | $39K | Buy |
|
|||||
2020
Q3 | $25K | Buy |
|
|||||
2020
Q2 | $20K | Buy |
|
|||||
2020
Q1 | $1K | Hold |
|
|||||
2019
Q4 | $0 | Sell |
|
|||||
2019
Q3 | $1K | Hold |
|
|||||
2019
Q2 | $3K | Hold |
|
|||||
2019
Q1 | $4K | Sell |
|
|||||
2018
Q4 | $11K | Sell |
|
|||||
2018
Q3 | $38K | Sell |
|
|||||
2018
Q2 | $49K | Buy |
|
|||||
2018
Q1 | $38K | Buy |
|
|||||
2017
Q4 | $12K | Hold |
|
|||||
2017
Q3 | $16K | Sell |
|
|||||
2017
Q2 | $32K | Sell |
|
|||||
2017
Q1 | $42K | Buy |
|
|||||
2016
Q4 | $6K | Hold |
|
|||||
2016
Q3 | $9K | Hold |
|
|||||
2016
Q2 | $12K | Buy |
|
|||||
2016
Q1 | $7K | Buy |
|
|||||
2015
Q4 | $7K | Hold |
|
|||||
2015
Q3 | $7K | Buy |
|